[Corticotropic effectiveness and allergenicity of the synthetic ACTH tetracoacetid synacthen depot].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000378:metabolism; D000311:Adrenal Glands / Q000187:drug effects*; D000324:Adrenocorticotropic Hormone / Q000009:adverse effects / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use; D000368:Aged; D001249:Asthma / Q000188:drug therapy; D003875:Drug Eruptions; D004804:Eosinophils; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007271:Injections, Intradermal; D007958:Leukocyte Count; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010902:Pituitary Gland; D012882:Skin Tests; D014020:Tissue Extracts / Q000494:pharmacology; D015032:Zinc
D015065:17-Hydroxycorticosteroids; D000305:Adrenal Cortex Hormones; D014020:Tissue Extracts; D000324:Adrenocorticotropic Hormone; D015032:Zinc; D006854:Hydrocortisone
Uber kortikotrope Wirksamkeit und Allergenität des synthetischen ACTH-Tetracosactids Synacthen-Depot.